PUBLISHED DATE : Jul 2019 | Pages : 266
Fill out your details & get your free sample
Coronary Stent Market Size, Share, & Trends Analysis Report by Product (Drug-Eluting, Bare Metal, and Bioresorbable Stents), Design (Permanent and Fully Degradable), End-Users (Hospitals, Specialty Cardiology Centers, and Ambulatory Surgical Centers), and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa), Industry Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Share & Forecast, 2019-2024
266 Pages
32 Tables
109 Charts
5 Regions
12 Countries
41 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (REVENUE) | USD 11 BILLION (2024) |
| CAGR | 7% (2019-2024) |
| Base Year | 2018 |
| Forecast Year | 2019-2024 |
| Market Segments | Product (Drug-Eluting, Bare Metal, and Bioresorbable Stents), Design (Permanent and Fully Degradable), End-Users (Hospitals, Specialty Cardiology Centers, and Ambulatory Surgical Centers) |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Countries Covered | Brazil, Canada, China, France, Germany, India, Japan, Mexico, Saudi Arabia, Turkey, UK, and US |
The coronary stent market size to cross USD 11 billion by 2024, and growing at a CAGR of 7% during the forecast period. The increasing prevalence of cardiovascular diseases (CVD), especially vascular diseases, has been a major growth driver for the global market. Over the years, coronary stent has witnessed several technological enhancements, particularly design innovations. Manufacturers are focusing primarily on R&D activities and commercialization of innovative drug-eluting stent (DES) systems due to the high prevalence of coronary artery diseases.
Several government agencies and vendors are spreading awareness and information about the availability of the latest-generation heart stent and its advantage over conventional invasive procedure. The emergence of bioresorbable vascular scaffolds, the high growth potential of third generation DESs with low strut thickness, and new product approvals and launches are some of the primary factors accelerating the global coronary stent market growth. Many surgeons are implanting DESs with low strut thickness for treating CAD. This is expected to increase the commercialization of a diverse range of DESs with low strut thickness, thereby positively contributing to the growth of the market globally.
Further, new product approvals are contributing majorly toward the growth of the industry and are likely to have a significant impact on the industry in the coming years. Abbott, B. Braun Melsungen, Boston Scientific, Biosensors International Group, Medtronic, BIOTRONIK, Microport Scientific, and Terumo have launched a diverse range of drug-eluting stent in recent years, which is expected to augur well for the growth of the global market.
The research report includes a detailed segmentation by
The high prevalence/incidence of CVDs is a major driver for the growth of drug-eluting stents. The high incidence of coronary artery disease(CAD), coupled with the increasing elderly population and complications such as heart attacks, is a significant factor driving the demand for drug-eluting stents.
Bare metal stent industry is growing at a steady rate. High CAD occurrences, technological advancements, and a steady increase in demand in emerging economies are factors responsible for growth of bare metal stent. Further, the demand for bare-metal stent is likely to grow primarily from price-sensitive industry such as developing and low-income countries, where the uptake of PCI procedures has steadily increased over the past few years.
Bioresorbable stent segment is growing at a faster pace and is likely to witness rapid growth during the forecast period. With the availability of a few commercial and promising investigational devices, bioresorbable product is likely to offer tremendous growth opportunities for vendors in coming years.
The permanent coronary stent segment is growing significantly and captured more than half of the market in 2018. Permanent heart stent is a non-degradable device made up from metal alloys such as stainless steel, cobalt chromium, and platinum chromium. They are gaining prominence due to their safety and efficacy.
Fully degradable heart stent industry is growing at a stable rate. The rise in CVDs, especially vascular & heart diseases, has become a major growth driver for innovative fully degradable types. Further, the manufacturers are focusing on R&D activities and commercialization of innovative products such as BRSs. Several emerging and major players are actively engaged in the research and development and commercialization of BRSs due to their huge potential. For instance, Abbott is developing Absorb, second-generation BRS, and is actively conducting clinical trials to gain regulatory approvals.
Hospitals are the largest end-users segment in the global industry. The growing aging population, changing lifestyle patterns, and the increasing prevalence of CVDs are fueling growth. Further, a significant number of patients prefer to undergo surgeries in hospitals due to better reimbursement policies. The availability of reimbursement in hospitals is a major driver for the high volume of PCI procedures in the healthcare sector. The demand for highly advanced and innovative PCI procedures like robot-assisted techniques are being performed to implant a diverse array of drug eluting, bare metal, and bioabsorbable type.
Specialty cardiology centers and interventional cardiology training are growing at a steady rate due to the presence of sophisticated infrastructure related to the diagnosis and treatment of CVDs. Significant advances in surgical procedures and the high demand for CVD care have also contributed to the growth of the segment. ASCs are outpatient surgery centers that provide advanced healthcare facilities to patients. These centers are cost-effective and offer quality care with the minimal indirect cost of treatment. Cohesively, these factors are expected to drive the global industry during the forecast period.
North America captured half of the global coronary stent market share in 2018. The presence of a large pool of patient population with CAD requiring, a high acceptance of advanced and innovative product, and high awareness toward stent-based PCI procedures have collectively supported North America’s dominance in the global industry.
Germany, the UK, France, Italy, and Spain are the major revenue contributors in the global coronary stent market in Europe. The presence of highly sophisticated healthcare infrastructure, high awareness regarding advantages of PCI procedures, and increased R&D investments on innovative coronary stents are major driver driving the Europe market.
APAC is likely to offer lucrative opportunities for a diverse range of coronary stents. Favorable government initiatives and the growing medical tourism industry in APAC are expected to drive the market in the region during the forecast period.
Latin America and MEA accounted small shares in 2018. Brazil and Mexico are the major revenue contributors in the Latin America region, whereas, Turkey, Saudi Arabia, South Africa, Israel, and a few Gulf countries are major revenue contributors in the MEA region.
The coronary stent market is highly dynamic due to the presence of several global, regional, and local players offering a broad range of products. Vendors, especially global players, are increasingly focusing on pursuing inorganic growth strategies such as acquisitions and investments in startup and emerging companies to expand their presence, enhance product portfolio, and improve expertise in the global industry. Leading players are focusing on implementing strategies such as product approvals, expanded indication approvals, conducting clinical trials, marketing, and promotional activities, acquisitions, increase R&D investment, and strengthen their distribution networks to enhance their industry share and presence in the market.
Market Segmentation by Product
By Design
By End-users
By Geography
Frequently Asked Questions
What is the coronary stent market size and growth rate during the forecast period?
Coronary stent market size will cross USD 11 billion by 2024, growing at a CAGR of 7%.
What are the factors influencing the global coronary stent market growth?
The growing prevalence of cardiovascular diseases (CVD), especially vascular diseases, has been a major growth driver for the global coronary stent market.
What are top trends, drivers, restraints, and opportunities in the global industry?
The emergence of bioresorbable vascular scaffolds, the high growth potential of third generation DESs with low strut thickness, technological advancements and innovations, and new product approvals and launches are major factors, which are expected to drive the market in coming years.
Who are the key player and what are their market shares?
Abbott, Boston Scientific, Medtronic, BIOTRONIK, Terumo, Braun Melsungen, Biosensors International Group are the leading market players having signification coronary stent market share.
Who are the major revenue contributors in the Europe region?
Germany, the UK, France, Italy, and Spain are the major revenue contributors in the global coronary stent market in Europe.
The global coronary stent market is likely to reach more than $11 billion by 2024, growing at a CAGR of around 7% during 2018–2024.
The market is undergoing several transformations. The emergence of bioresorbable vascular scaffolds, the high growth potential of third generation DESs with low strut thickness, technological advancements and innovations, and new product approvals and launches are major factors, which are expected to drive the market in coming years.
Base Year: 2018
Forecast Year: 2019–2024
The study considers the present scenario of the market and its market dynamics for the period 2019−2024. The report covers a detailed overview of several market growth enablers, restraints, and trends. It covers both the demand and supply aspect of the market. It profiles and examines leading and prominent companies operating in the market.
Prominent Vendors
Other Prominent Vendors
Market Segmentation by Product
Market Segmentation by Design
Market Segmentation by End-users
Market Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the study
4.4 Market Segments
4.4.1 Coronary Stent Market Segmentation by Products
4.4.2 Coronary Stent Market Segmentation by Design
4.4.3 Coronary Stent Market Segmentation by End-users
4.4.4 Coronary Stent Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Coronary Artery Disease (CAD): An Overview
7.1.1 Symptoms
7.1.3 Etiology
7.1.4 Complications
7.1.5 Diagnosis
7.1.6 Treatment
7.2 PCI: An Overview
7.2.1 Coronary Stents
8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Increased Prevalence/Incidence of Coronary Artery Disease
8.1.2 High Demand for DESs with Low Strut Thickness
8.1.3 High Demand for Coronary Stents in Emerging Markets
8.1.4 Technological Advancements/Innovations in Stent Platforms
8.2 Market Growth Restraints
8.2.1 Stringent Regulations for Product Approvals
8.2.2 Availability of Alternative Treatment Methods for CAD
8.2.3 Complications Associated with Coronary Stenting Procedure
8.3 Coronary Stent Market Opportunities & Trends
8.3.1 Emergence of Bioresorbable Vascular Scaffolds
8.3.2 High Growth Potential of Third-generation DESs
8.3.3 New Product Approvals/Launches
9 Global Coronary Stent Market
9.1 Coronary Stent Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 By Product Type
10.1 Market Snapshot & Growth Engine
10.2 Coronary Stent Market Overview by Product type
10.3 Drug-eluting Stents
10.3.1 Market Overview
10.3.2 Market Size & Forecast
10.3.3 Global Drug-eluting Stents Market by Product Type
10.3.4 Second-generation Drug-eluting Stents: Market Size & Forecast
10.3.5 Latest-generation Drug-eluting Stents: Market Size & Forecast
10.4 Bare Metal Stents
10.4.1 Market Overview
10.4.2 Market Size & Forecast
10.5 Bioresorbable Stents
10.5.1 Market Overview
10.5.2 Market Size & Forecast
11 By Design Type
11.1 Market Snapshot & Growth Engine
11.2 Coronary Stent Market Overview by Design type
11.3 Permanent Coronary Stents
11.3.1 Market Size & Forecast
11.4 Fully Degradable Coronary Stents
11.4.1 Market Size & Forecast
12 By End-Users
12.1 Market Snapshot & Growth Engine
12.2 Coronary Stent Market Overview by End-users
12.3 Hospitals
12.3.1 Market Size & Forecast
12.4 Specialty Cardiology Centers
12.4.1 Market Size & Forecast
12.5 ASCs
12.5.1 Market Size & Forecast
13 By Geography
13.1 Market Snapshot & Growth Engine
13.2 Coronary Stent Market Overview by Geography
14 North America
14.1 Market Overview
14.2 Market Size & Forecast
14.3 Key Countries
14.3.1 US: Coronary Stent Market Size & Forecast
14.3.2 Canada:Coronary Stent Market Size & Forecast
15 Europe
15.1 Market Overview
15.1.1 Market Size & Forecast
15.2 Key Countries
15.2.1 Germany:Coronary Stent Market Size & Forecast
15.2.2 France:Coronary Stent Market Size & Forecast
15.2.3 UK:Coronary Stent Market Size & Forecast
16 APAC
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Key Countries
16.3.1 Japan:Coronary Stent Market Size & Forecast
16.3.2 China: Coronary Stent Market Size & Forecast
16.3.3 India:Coronary Stent Market Size & Forecast
17 Latin America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Key Countries
17.3.1 Brazil:Coronary Stent Market Size & Forecast
17.3.2 Mexico:Coronary Stent Market Size & Forecast
18 Middle-East and Africa
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Key Countries
18.3.1 Turkey:Coronary Stent Market Size & Forecast
18.3.2 Saudi Arabia:Coronary Stent Market Size & Forecast
19 Competitive Landscape
19.1 Competition Overview
19.2 Market Share Analysis
20 Key Company Profiles
20.1 Abbott
20.1.1 Business Overview
20.1.2 Abbott in Global Coronary Stents Market
20.1.3 Major Product Offerings
20.1.4 Key Strategies
20.1.5 Key Strengths
20.1.6 Key Opportunities
20.2 Boston Scientific
20.2.1 Business Overview
20.2.2 Boston Scientific in Global Coronary Stents Market
20.2.3 Major Product Offerings
20.2.4 Key Strategies
20.2.5 Key Strengths
20.2.6 Key Opportunities
20.3 Medtronic
20.3.1 Business Overview
20.3.2 Medtronic in Global Coronary Stent Market
20.3.3 Major Product Offerings
20.3.4 Key Strategies
20.3.5 Key Strengths
20.3.6 Key Opportunities
20.4 Biotronik
20.4.1 Business Overview
20.4.2 BIOTRONIK in Global Coronary Stents Market
20.4.3 Major Product Offerings
20.4.4 Key Strategies
20.4.5 Key Strengths
20.4.6 Key Opportunities
20.5 Terumo
20.5.1 Business Overview
20.5.2 Terumo in Global Coronary Stents Market
20.5.3 Product Offerings
20.5.4 Key Strategies
20.5.5 Key Strengths
20.5.6 Key Opportunities
20.6 B. Braun Melsungen
20.6.1 Business Overview
20.6.2 B. Braun Melsungen in Global Coronary Stents Market
20.6.3 Major Product Offerings
20.6.4 Key Strategies
20.6.5 Key Strengths
20.6.6 Key Opportunities
20.7 Biosensors International Group
20.7.1 Business Overview
20.7.2 Biosensors International Group in Global Coronary Stents Market
20.7.3 Major Product Offerings
20.7.4 Key Strategies
20.7.5 Key Strengths
20.7.6 Key Opportunities
21 Other Prominent Vendors
21.1 Arterial Remodeling Technologies
21.1.1 Business Overview
21.1.2 Major Product Offerings
21.2 Alvimedica
21.2.1 Business Overview
21.2.2 Major Product Offerings
21.3 Balton
21.3.1 Business Overview
21.3.2 Major Product Offerings
21.5 Cardionovum
21.5.1 Business Overview
21.5.2 Major Product Offerings
21.6 CeloNovaBioSciences
21.6.1 Business Overview
21.6.2 Major Product Offerings
21.7 Comed
21.7.1 Business Overview
21.7.2 Major Product Offerings
21.8 Cordis
21.8.1 Business Overview
21.8.2 Major Product Offerings
21.9 Elixir Medical
21.9.1 Business Overview
21.9.2 Major Product Offerings
21.10 ENDOCOR
21.10.1 Business Overview
21.10.2 Major Product Offerings
21.11 Eucatech
21.11.1Business Overview
21.11.2Major Product Offerings
21.12 Eurocor Tech
21.12.1Business Overview
21.12.2Major Product Offerings
21.13 HEXACATH
21.13.1Business Overview
21.13.2Major Product Offerings
21.14 InSitu Technologies
21.14.1Business Overview
21.14.2Major Product Offerings
21.15 Innovative Health Technologies
21.15.1Business Overview
21.15.2Major Product Offerings
21.16 Lepu Medical Technology (Beijing)
21.16.1Business Overview
21.16.2Major Product Offerings
21.17 Medinol
21.17.1Business Overview
21.17.2Major Product Offerings
21.18 Meril Life Sciences
21.18.1Business Overview
21.18.2Major Product Offerings
21.19 Micell Technologies
21.19.1Business Overview
21.19.2Major Product Offerings
21.20 MicroPort Scientific
21.20.1 Business Overview
21.20.2Major Product Offerings
21.21 Minvasys
21.21.1Business Overview
21.21.2 Major Product Offerings
21.22 ORBUSNEICH MEDICAL
21.22.1Business Overview
21.22.2Major Product Offerings
21.23 Q3 Medical Devices
21.23.1Business Overview
21.23.2Major Product Offerings
21.24 REVA Medical
21.24.1Business Overview
21.24.2Major Product Offerings
21.25 Rontis
21.25.1Business Overview
21.25.2Major Product Offerings
21.26 S3V Vascular Technologies
21.26.1Business Overview
21.26.2Major Product Offerings
21.27 Sahajanand Medical Technologies
21.27.1Business Overview
21.27.2Major Product Offerings
21.28 SCITECH
21.28.1Business Overview
21.28.2Major Product Offerings
21.29 STENTYS
21.29.1Business Overview
21.29.2Major Product Offerings
21.30 Svelte Medical
21.30.1 Business Overview
21.30.2Major Product Offerings
21.31 Translumina Therapeutics
21.31.1Business Overview
21.31.2Major Product Offerings
21.32 USM HEALTHCARE
21.32.1Business Overview
21.32.2Major Product Offerings
21.33 Vascular Concepts
21.33.1Business Overview
21.33.2Major Product Offerings
21.34 Wellinq
21.34.1Business Overview
21.34.2Major Product Offerings
22 Report Summary
22.1 Key Takeaways
22.2 Strategic Recommendations
22.3 Quantitative Summary
22.3.1 Product Type
22.3.2 Design Type
22.3.3 End-Users
22.3.4 Geography
23 Appendix
23.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global Coronary Stent Market
Exhibit 2 Market Size Calculation Approach 2018
Exhibit 3 Evolution of Coronary Stents for Treating CAD
Exhibit 4 Different Types of Coronary Stents Available in the Market
Exhibit 5 Impact of Increased Prevalence/Incidence of Coronary Artery Disease
Exhibit 6 Impact of High Demand for DESs with Low Strut Thickness
Exhibit 7 Impact of High Demand for Coronary Stents in Emerging Markets
Exhibit 8 Incremental Growth of Coronary Stents Market in India
Exhibit 9 Incremental Growth of Coronary Stents Market in China
Exhibit 10 Impact of Technological Advancements/Innovations in Stent Platforms
Exhibit 11 Impact of Stringent Regulations for Product Approvals
Exhibit 12 Impact of Availability of Alternative Treatment Methods for CAD
Exhibit 13 Impact of Complications Associated with Coronary Stenting Procedure
Exhibit 14 Impact of Emergence of Bioresorbable Vascular Scaffolds
Exhibit 15 Impact of High Growth Potential of Third-generation DESs
Exhibit 16 Impact of New Product Approvals/Launches
Exhibit 17 Market by Product Type 2018 (%)
Exhibit 18 Market By Geography 2018 & 2024 (%)
Exhibit 19 Key Countries
Exhibit 20 Market By Region: Incremental Growth
Exhibit 21 Global Coronary Stent Market 2018−2024 ($ million)
Exhibit 22 Five Forces Analysis 2018
Exhibit 23 Incremental Growth by Product 2018−2024
Exhibit 24 Market by Product Type
Exhibit 25 Market by Product Type 2018 & 2024 (%)
Exhibit 26 Market by Product Type 2018−2024 ($ million)
Exhibit 27 Market by Product Type 2018−2024 (%)
Exhibit 28 Market by Product Type: Absolute Growth
Exhibit 29 Global Drug-eluting Coronary Stent Market 2018−2024 ($ million)
Exhibit 30 Global Drug-eluting Stents Market by Product Type
Exhibit 31 Global Drug-eluting Stents Market by Product Type 2018 & 2024 (%)
Exhibit 32 Global Drug-eluting Stents Market by Product Type 2018−2024 ($ million)
Exhibit 33 Global Drug-eluting Stents Market by Product Type 2018−2024 (%)
Exhibit 34 Global Second-generation Drug-eluting Stents Market 2018−2024 ($ million)
Exhibit 35 Global Latest-generation Drug-eluting Stents Market 2018−2024 ($ million)
Exhibit 36 Global Bare Metal Coronary Stent Market 2018−2024 ($ million)
Exhibit 37 Global Bioresorbable Coronary Stent Market 2018−2024 ($ million)
Exhibit 38 Incremental Growth by Design 2018−2024
Exhibit 39 Market by Design Type
Exhibit 40 Market by Design Type 2018 & 2024 (%)
Exhibit 41 Market by Design Type 2018−2024 ($ million)
Exhibit 42 Market by Design Type 2018−2024 (%)
Exhibit 43 Market by Design Type: Absolute Growth
Exhibit 44 Global Permanent Coronary Stent Market by Product 2018 (%)
Exhibit 45 Global Permanent Coronary Stent Market 2018−2024 ($ million)
Exhibit 46 Global Fully Degradable Coronary Stent Market 2018−2024 ($ million)
Exhibit 47 Incremental Growth by End-users 2018−2024
Exhibit 48 Market by End-user Type
Exhibit 49 Market by End-users: Absolute Growth
Exhibit 50 Market by End-user Type 2018 & 2024 (%)
Exhibit 51 Market by End-user Type 2018−2024 ($ million)
Exhibit 52 Market by End-user Type 2018−2024 (%)
Exhibit 53 Global Coronary Stents Hospitals Market 2018–2024 ($ million)
Exhibit 54 Market by SCCs 2018–2024 ($ million)
Exhibit 55 Market by ASCs 2018–2024 ($ million)
Exhibit 56 Incremental Growth by Geography 2018−2024
Exhibit 57 Market by Geography
Exhibit 58 Market by Region: Market Share & CAGR
Exhibit 59 Market by Region: Absolute Growth
Exhibit 60 Market by Geography 2018 & 2024 (%)
Exhibit 61 Market by Geography 2018 & 2024 (%)
Exhibit 62 Market by Geography 2018 & 2024 (%)
Exhibit 63 Market in North America by Country 2018 (%)
Exhibit 64 Market in North America 2018–2024 ($)
Exhibit 65 Incremental Growth in North America 2018−2024
Exhibit 66 Market in US 2018–2024 ($ million)
Exhibit 67 Market in Canada 2018−2024 ($ million)
Exhibit 68 Market in Europe: Key Countries
Exhibit 69 Market in Europe 2018−2024 ($ million)
Exhibit 70 Incremental Growth in Europe 2018−2024
Exhibit 71 Market in Germany 2018−2024 ($ million)
Exhibit 72 Market in France 2018−2024 ($ million)
Exhibit 73 Market in UK 2018−2024 ($ million)
Exhibit 74 Incremental Growth Comparison Across Regions During Forecast Period ($ Mn)
Exhibit 75 Market in APAC: Key Countries
Exhibit 76 Market in APAC 2018−2024 ($ million)
Exhibit 77 Incremental Growth in APAC 2018−2024
Exhibit 78 Market in Japan 2018−2024 ($ million)
Exhibit 79 Market in China 2018−2024 ($ million)
Exhibit 80 Major Factors Driving Coronary Stents Market in India
Exhibit 81 Coronary Stents Market in India 2018−2024 ($ million)
Exhibit 82 Market in Latin America: Key Countries
Exhibit 83 Coronary Stents Market in Latin America 2018−2024 ($ million)
Exhibit 84 Incremental Growth in Latin America 2018−2024
Exhibit 85 Coronary Stents Market in Brazil 2018−2024 ($ million)
Exhibit 86 Coronary Stents Market in Mexico 2018−2024 ($ million)
Exhibit 87 Market in MEA: Key Countries
Exhibit 88 Coronary Stents Market in MEA 2018−2024 ($ million)
Exhibit 89 Incremental Growth in MEA 2018−2024
Exhibit 90 Coronary Stents Market in Turkey 2018−2024 ($ million)
Exhibit 91 Market in Saudi Arabia 2018−2024 ($ million)
Exhibit 92 Market: Vendors Market Share 2018 (%)
Exhibit 93 Market: Top Vendors Market Shares 2018 (%)
Exhibit 94 Abbott: R&D Spend in FY2016, FY2017 and FY2018 ($ million)
Exhibit 95 Abbott: Sales Breakdown by Segments in FY2017 and FY2018 ($ million)
Exhibit 96 Abbott Sales Breakdown by Geography 2018 (%)
Exhibit 97 Boston Scientific: R&D Expenditure in FY16, FY17 and FY18 ($ million)
Exhibit 98 Boston Scientific: Revenue Breakdown by Product Category 2017 and 2018 ($ million)
Exhibit 99 Boston Scientific: Revenue Share by Geography 2018 (%)
Exhibit 100 Medtronic Sales Breakdown by Segments FY2018 (%)
Exhibit 101 Medtronic R&D Expenditure FY16-FY18 ($ million)
Exhibit 102 Medtronic Revenue Breakdown by Geography FY2018 (%)
Exhibit 103 Medtronic Revenue by Business Segments in FY17 and FY18 ($ million)
Exhibit 104 Terumo: Research & Development Spend in FY15, FY16, and FY17 ($ million)
Exhibit 105 Terumo: Sales by Business Segment in FY2017 (%)
Exhibit 106 Terumo: Cardiovascular Revenue by Geography FY2017 (%)
Exhibit 107 B. Braun Melsungen R&D Expenditure in FY16, FY17, and FY18 ($ million)
Exhibit 108 B. Braun Melsungen Revenue by Division FY2017 and FY2018 ($ million)
Exhibit 109 B. Braun Melsungen Sales by Region FY18 (%)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2018
Table 3 Historical Milestones in Coronary Artery Stenting
Table 4 Popular DESs with Low Strut Thickness
Table 5 Absolute Growth of Coronary Stents in Developed and Emerging Economies (%)
Table 6 List of Major Advanced and Innovative Coronary Stents
Table 7 Commercially Available Bioresorbable Coronary Stents
Table 8 Investigational Bioresorbable Coronary Stents
Table 9 List of Popular Biodegradable Polymer Coating Drug-eluting Stents
Table 10 Recent Product Approvals in Global Coronary Stent Market
Table 11 List of Popular DESs from Prominent Players
Table 12 List of Popular BMSs from Prominent Players
Table 13 Commercially Available Bioresorbable Stents
Table 14 Investigational Bioresorbable Stents
Table 15 Market: Vendors Ranking 2018
Table 16 Abbott: Product Offerings
Table 17 Boston Scientific: Key Product Approval Milestone
Table 18 Boston Scientific: Product Offerings
Table 19 Medtronic: Product Offerings
Table 20 BIOTRONIK: Product Offerings
Table 21 Terumo: Product Offerings
Table 22 B. Braun Melsungen’s Therapy Fields & Applications
Table 23 B. Braun Melsungen: Product Offerings
Table 24 Biosensors International Group: Product Offerings
Table 25 Market by Product Type ($ million)
Table 26 Market by Product Type (%)
Table 27 Market by Design ($ million)
Table 28 Market by Design (%)
Table 29 Market by End-users ($ million)
Table 30 Market by End-users (%)
Table 31 Market by Geography ($ million)
Table 32 Market by Geography (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
